<!-- google_ad_section_start -->Islet Viability During Transplantation<!-- google_ad_section_end -->
Health Forums

Go Back   Health Forums > Diseases and Conditions > Diabetes > alt.support.diabetes

Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 05-03-2008, 01:31 PM
ironjustice
Guest
 
Posts: n/a
Default Islet Viability During Transplantation

"Iron chelation may improve islet viability"

Overexpression of vascular endothelial growth factor in vitro using
deferoxamine: a new drug to increase islet vascularization during
transplantation.
Langlois A, Bietiger W, Mandes K, Maillard E, Belcourt A, Pinget M,
Kessler L, Sigrist S
Transplant Proc 2008 Mar; 40(2):473-6.

During pancreatic islet transplantation, delayed and insufficient
revascularization can deprive islets of oxygen and nutrients,
resulting in cell death and early graft failure. Deferoxamine (DFO),
an iron chelator, increases vascular endothelial growth factor (VEGF)
expression in cells. The aim of this work was to study the effect of
DFO on beta-cell and pancreatic islet viability as well as VEGF
expression. beta-cell lines from rat insulinoma (Rin m5f) and primary
cultures of pancreatic islets from Wistar rats were incubated with DFO
(10, 100, and 1000 mumol/L). The viability was evaluated using
fluorescein diacetate/propidium iodide for dying pancreatic islets and
using cell titers for Rin m5f. Expression of VEGF messenger RNA (mRNA)
was quantified using reverse transcriptase polymerase chain reaction
(RT-PCR). Finally, VEGF secretion was determined using enzyme-linked
immunosorbent assays at 1 to 3 days after treatment. The addition of
10 mumol/L of DFO preserved Rin m5F viability at 24 hours after
treatment (10 mumol/L; 101.33% +/- 5.66%; n = 7). However, 100 and
1000 mumol/L of DFO induced cell death (68.92% +/- 5.83% and 65.89%
+/- 5.83%, respectively; n = 4). In the same way, viability of
pancreatic islets in the presence of DFO was preserved. RT-PCR
analysis showed stimulation of VEGF mRNA in the presence of 10 mumol/L
of DFO in islets at 3 days after culture. Finally, 10 mumol/L of DFO
stimulated secretion of VEGF 7.95 +/- 0.84 versus 1.80 +/- 1.10 pg/mug
total protein with 10 mumol/L of DFO in rat islets at 3 days after
culture, n = 3; P < .001). The use of DFO to stimulate VEGF expression
and increase islet vascularization may be a realistic approach to
improve islet viability during transplantation.
Transplantation proceedings [Transplant Proc]
---------------------------------------------------------------------------*-----


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh


Man Is A Herbivore!
http://tinyurl.com/a3cc3


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is Off
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Islet cells in the lab... Blue Streak alt.support.diabetes 2 03-19-2008 11:48 AM
Omega-3 fatty-acid intake reduces the risk of islet autoimmunityin children at high risk for diabetes Susan alt.support.diabetes 0 10-03-2007 02:21 AM
Fat-soluble thiamine (Benfotiamine) and The Islet Foundation Chris Hogg alt.support.diabetes 0 08-14-2007 11:10 PM
Preventing Marrow Transplantation ironjustice@aol.com alt.support.cancer 0 08-06-2007 05:44 PM


All times are GMT. The time now is 11:05 AM.


Powered by vBulletin® Version 3.7.2
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
Search Engine Optimization by vBSEO 3.2.0
     
   
 

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41